Additionally, YBX1 collaborates with m5C regulatory genes to develop risk prediction models for prostate cancer and kidney renal papillary cell carcinoma (KIRP) [132,133] and with genes associated with tumor-infiltrating CD8+ T cells to establish risk prediction models for papillary renal cell carcinoma (papRCC) [134]. The gene discussed is YBX1; the disease is neoplasm.